Diabetes Breakthrough: Atrial Natriuretic Peptide Levels Offer New Hope for Treatment
The study looked at the levels of a hormone called atrial natriuretic peptide (ANP) in diabetic male rats. The researchers divided the rats into different groups and measured their glucose levels, ANP levels, and other physiological parameters. They found that the rats with diabetes had higher glucose levels and ANP levels compared to the healthy rats. Treating the diabetic rats with a medication called foxiga helped lower their glucose levels. The levels of ALP, ALT, and AST enzymes were also higher in the diabetic rats. Overall, the study showed that ANP levels were elevated in diabetic rats and could be influenced by treatment with foxiga.